美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CAR-T

1,728.61

-5.2981-0.31%

漲家數：1

跌家數：1

平家數：- -

市盈率：- -

高：1,732.48

開：1,732.01

低：1,705.45

收：1,733.91

成交量：404.53萬

成交額：5.75億

市值：4,455.26億

流通市值：4,372.51億

資料載入中...

總覽新聞資訊

諾華DM1藥物III期臨床試驗未達到主要終點

繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗

諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。

諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力

一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」

諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。

諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標

通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型

諾華公司：計劃停止克萊因巴塞爾生產基地的生產可能導致約130個工作崗位流失。所有計劃中的變更均需經過信息告知與協商程序。

諾華集團：高效口服BTK抑制劑瑞米布替尼在III期RMS臨床試驗中顯著降低複發率安全性表現良好

諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破

美股異動 | 諾華製藥升逾5%，MS口服藥後期試驗告捷

諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了

TradingKey中文

諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷

諾華暫停該項目，此前已報告3起嚴重的免疫效應細胞相關噬血細胞綜合徵病例，併發症最終導致患者死亡。

諾華：出現死亡病例，暫停自身免疫細胞療法相關研究

邦順製藥赴港IPO，創始團隊出自華東醫藥，面臨諾華、澤璟製藥的競爭

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BK4578/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1728.6112,"timestamp":1789500082684,"preClose":1733.9093,"halted":0,"volume":4045352,"delay":0,"changeRate":-0.003056,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-5.298096,"latestTime":"09-15 15:21:23 EDT","open":1732.0104,"high":1732.4797,"low":1705.446,"amount":575139751.950361,"amplitude":0.015591,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.300443,"peRate":46.548588,"turnoverRate":0.00131,"increases":0,"decrements":2,"flats":0,"marketCap":445525884928,"floatMarketCap":437251489792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1732.4797,"amplitude":0.015591,"preClose":1733.9093,"low":1705.446,"pbRate":"8.300443","latestPrice":1728.6112,"volume":4045321,"delay":0,"open":1732.0104,"prevYearClose":1612.5378,"prevWeekClose":1707.2908,"prevMonthClose":1830.2803,"prevQuarterClose":1768.1697,"fiveDayClose":1725.5667,"twentyDayClose":1794.044,"sixtyDayClose":1684.6451,"secType":"PLATE","market":"US","turnoverRate":0.001309,"peRate":46.548588,"marketCap":445513482240,"floatMarketCap":437239103488,"timestamp":1789500079452,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665342373","title":"諾華DM1藥物III期臨床試驗未達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PPH","BK4588","BK4578","LU0070302665.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IBBQ","BMED","PSYK","NVS","MDTX","BK4585","IBBJ","IE00BJT1NW94.SGD","BK4532","IE00BJJMRZ35.SGD","BK4007","IE00B2B36J28.USD","LU0320765489.SGD","LU0208291251.USD","IE0009355771.USD","LU0211331839.USD","IE0002141913.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831989","title":"繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:10","pubTimestamp":1788779458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002141913.USD","BK4585","BMED","LU0211331839.USD","BK4532","MDTX","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4588","BK4578","IE00B4R5TH58.HKD","MEDX","IBBQ","IE00B2B36J28.USD","LU0320765489.SGD","BGIA","IBBJ","PPH","PSYK","LU0070302665.USD","BK4007","NVS","LU0208291251.USD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397441","title":"諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:42","pubTimestamp":1788766955,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","NVS","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","MEDX","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0320765489.SGD","BK4532","BK4578","LU0208291251.USD","BK4588","PPH","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739206","title":"諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739206","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:24","pubTimestamp":1788765896,"startTime":"0","endTime":"0","summary":"诺华股价下跌，因一项胆固醇药物研究失败加剧了研发管线压力路透伦敦9月7日-诺华公司的股价周一早盘下跌3.3%，此前该公司的一款降胆固醇药物在一项备受关注的研究中未能达到预期效果，这使得该疗法再次受到质疑，同时也提高了这家瑞士制药商即将公布的基因疗法数据所面临的压力。上周五晚间，诺华表示，在其针对高Lp 患者进行的一项大型晚期研究中，其药物佩拉卡森  未能降低心脏病发作和中风的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","BK4585","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4578","PPH","BK4532","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","NVS","IE0009355771.USD","LU0070302665.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","MEDX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1571399168.USD","LU2242646821.SGD","LU2468319806.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","BK4139","PJP","BK4007","LU2112291526.USD","BK4533","MEDX","PBE","LU0058720904.USD","IE00B4R5TH58.HKD","NVS","LU0208291251.USD","BIB","SG9999001440.SGD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4566","BK4534","LU0109394709.USD","LU0320765992.SGD","AMGN","LU0868494617.USD","BBH","IBBQ","PPH","LU1023059063.AUD","IE00B2B36J28.USD","BK4532","BK4585","BK4578","IE0009355771.USD","IE0002141913.USD","LU2242652126.USD","IE00BJT1NW94.SGD","BK4581","LU0320765489.SGD","LU0070302665.USD","LU0289739699.SGD","LU0211331839.USD","BK4588","LU0889565916.HKD","IBB","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394493","title":"諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394493","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394493?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:30","pubTimestamp":1788762634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","BK4009","IE0009355771.USD","IE00B4R5TH58.HKD","LU0211331839.USD","BK4585","IE0002141913.USD","MEDX","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","LU0208291251.USD","NVS","BAOS","PPH","IE00B2B36J28.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4588","LU0070302665.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394397","title":"諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","BK4533","LU0122379950.USD","LU0306806265.USD","LU1066051498.USD","SG9999011175.SGD","SG9999002232.USD","SG9999001176.SGD","LU1023059063.AUD","OZEM","BK4581","BK4588","LU1883839398.USD","BK4585","LU0225284248.USD","BK4592","LU0985481810.HKD","PFE","IE00BLSP4452.SGD","BK4578","BK4550","IE00B19Z3581.USD","LU0170899867.USD","LU0211331839.USD","LU1894683264.USD","LU1894683348.USD","IE0002141913.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0321505439.SGD","LU2596442595.SGD","LU0289739699.SGD","SG9999003800.SGD","IE00B2B36J28.USD","BK4599","SG9999002224.SGD","IE0002270589.USD","BK4568","LU0208291251.USD","IE00BBT3K403.USD","LU0070302665.USD","LU0234572021.USD","LU0058720904.USD","LU1057294990.SGD","IE00B3T34201.USD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","MEDX","BK4534","SGXZ57979304.SGD","PPH","SG9999001176.USD","LU0225771236.USD","LU1066053197.SGD","LU0321505868.SGD","BK4532","IE0009355771.USD","LU0320765489.SGD","NVS","LU0306807586.USD","LU0456855351.SGD","LU0868494617.USD","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664694879","title":"通用電氣維諾華公司：與愛爾蘭國家電力公司達成協議，將為蘇格蘭高地的96兆瓦奇倫塞德風電場供應16台6.1兆瓦-158米型","url":"https://stock-news.laohu8.com/highlight/detail?id=2664694879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664694879?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:17","pubTimestamp":1788434237,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0208291251.USD","LU0070302665.USD","IE00B2B36J28.USD","PPH","IE00BFTCPJ56.SGD","NVS","LU0320765489.SGD","BK4585","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","BK4532","BK4007","LU0211331839.USD","IE0009355771.USD","MEDX","IE0002141913.USD","BK4588","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811784","title":"諾華公司：計劃停止克萊因巴塞爾生產基地的生產可能導致約130個工作崗位流失。所有計劃中的變更均需經過信息告知與協商程序。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811784","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811784?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 20:37","pubTimestamp":1788352638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0009355771.USD","LU0211331839.USD","BK4532","BK4578","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0070302665.USD","NVS","LU0320765489.SGD","PPH","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","MEDX","BK4007","BK4585","HELS","LU0208291251.USD","IE0002141913.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815045","title":"諾華集團：高效口服BTK抑制劑瑞米布替尼在III期RMS臨床試驗中顯著降低複發率 安全性表現良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815045","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815045?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:11","pubTimestamp":1788347485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IE0002141913.USD","BK4532","IE00BJJMRZ35.SGD","NVS","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","PPH","BK4578","MDTX","MEDX","IE00BFTCPJ56.SGD","LU0208291251.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","IBBJ","LU0070302665.USD","PSYK","BK4007","IE0009355771.USD","LU0211331839.USD","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850928","title":"諾華製藥（NVS）漲6% 在BTK抑制劑賽道迎來重要突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850928","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664850928?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 23:18","pubTimestamp":1788275914,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺华制药 早盘股价扬升，最新涨6%，报161.2美元，成交额3.2亿美元。诺华周二公布，对比对照药物特立氟胺，瑞米布替尼可降低患者疾病复发率，减少脑部病灶数量，试验中未观察到肝脏相关安全风险。该药有望成为诺华重磅产品Kesimpta的后续迭代品种，同时印证BTK抑制剂在抑制异常免疫反应方面的治疗潜力。诺华计划向全球监管机构提交瑞米布替尼治疗多发性硬化症的上市申请，完整临床数据将于今年晚些时候在多伦多医学会议对外披露。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YmFmZjgzNDhkMjgxZmE5MWVmYzk4MzgzNTg2ODExODg1NTU0MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK1191","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK1574","NVS","LU0208291251.USD","BK4585","BK4532","IE00BJT1NW94.SGD","BK4588","PPH","01477","IE0002141913.USD","BK4007","BK4578","IE00BJJMRZ35.SGD","MEDX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664016854","title":"美股異動 | 諾華製藥升逾5%，MS口服藥後期試驗告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664016854","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664016854?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:35","pubTimestamp":1788273301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，诺华制药涨逾5%，报160.82美元。消息面上，诺华表示，试验显示，接受瑞米布替尼治疗的患者与接受特立氟胺治疗的患者相比，复发率和脑部病变数量均有所减少，且未观察到肝脏安全信号。该药有望为诺华提供一种治疗多发性硬化症的新型口服药物，并成为其重磅产品Kesimpta系列的后续产品。此前，赛诺菲和默克公司的类似药物在后期试验中未能在复发率指标上优于特立氟胺。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490652.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华制药MS口服药后期试验告捷","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IE00BFTCPJ56.SGD","BK4532","IE00B4R5TH58.HKD","NVS","BK1191","IE0002141913.USD","PPH","LU0211331839.USD","BK4007","LU0320765489.SGD","BK4578","IE00BJT1NW94.SGD","MEDX","LU0208291251.USD","BK1574","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4585","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664524478","title":"諾華製藥(NVS)股票9月1日盤中上漲6.54%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2664524478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664524478?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:16","pubTimestamp":1788272176,"startTime":"0","endTime":"0","summary":"• Remibrutinib 在三期多发性硬化症试验中取得成功，展现出临床优效性。\n• 在三名患者死亡后，诺华暂停了八项早期 CAR-T 试验。\n• 该公司报告年收入为 563.3 亿美元，净利润为 139.8 亿美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262144173-market-movers-nvs-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","BK1574","IE00BJJMRZ35.SGD","NVS","01477","BK4007","BK4588","LU0211331839.USD","IE00BFTCPJ56.SGD","MEDX","PPH","BK4578","BK1191","LU0070302665.USD","BK4532","IE0009355771.USD","IE0002141913.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831619","title":"諾華製藥(NVS.US)神經免疫管線「悲喜交加」：患者死亡致CAR-T臨床試驗暫停 MS口服藥後期試驗告捷","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831619?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:40","pubTimestamp":1788248407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药在神经与自身免疫领域迎来“冰火两重天”：公司因三名患者死亡紧急叫停八项CAR-T疗法临床试验;不过，其多发性硬化症口服药remibrutinib在后期临床试验中取得积极结果。CAR-T试验紧急暂停诺华制药在8月底暂停了八项针对自身免疫和神经系统疾病的实验性疗法临床试验，此前有三名患者死亡。诺华制药发言人表示，公司正在“对所观察到的安全事件进行全面审查”，并将这种致命免疫反应描述为CAR-T疗法中已知的安全风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","BK4578","MDTX","BK1191","MEDX","BMED","01477","IE00B2B36J28.USD","BK1574","IE00BFTCPJ56.SGD","BK4532","BK4588","LU0320765489.SGD","LU0070302665.USD","IE00B4R5TH58.HKD","BK4585","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD","PPH","IE0009355771.USD","IE00BJJMRZ35.SGD","NVS","LU0211331839.USD","BK4007","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664839602","title":"諾華暫停該項目，此前已報告3起嚴重的免疫效應細胞相關噬血細胞綜合徵病例，併發症最終導致患者死亡。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664839602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664839602?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:23","pubTimestamp":1788247409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","LU0211331839.USD","IE00B2B36J28.USD","BK4585","NVS","IE00BFTCPJ56.SGD","LU0320765489.SGD","LU0208291251.USD","BK4588","LU0070302665.USD","BK4007","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","IE00BJJMRZ35.SGD","MEDX","PPH","BK4532","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800188","title":"諾華：出現死亡病例，暫停自身免疫細胞療法相關研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800188","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800188?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 12:21","pubTimestamp":1788236460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WDNA","IE00B2B36J28.USD","IE00B4R5TH58.HKD","CNCR","LU0320765489.SGD","NVS","BK4588","MEDX","BK4578","BK4532","LU0070302665.USD","LU0211331839.USD","BK4007","IE00BJT1NW94.SGD","BK4585","LU0208291251.USD","IE00BFTCPJ56.SGD","SYNB","IE00BJJMRZ35.SGD","PPH","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882712","title":"邦順製藥赴港IPO，創始團隊出自華東醫藥，面臨諾華、澤璟製藥的競爭","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882712","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882712?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 10:21","pubTimestamp":1788229285,"startTime":"0","endTime":"0","summary":"两年半累计亏损4.67亿","market":"us","thumbnail":"https://img2.gelonghui.com/bf122-cc396b77-81ef-4c91-ae6d-db59d48043ce.jpg?guru_height=909&guru_width=1473&guru_size=100893","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/bf122-cc396b77-81ef-4c91-ae6d-db59d48043ce.jpg?guru_height=909&guru_width=1473&guru_size=100893"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6439376","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IE00BFTCPJ56.SGD","BK0196","LU0211331839.USD","REDS","01477","FRHC","PPH","MEDX","BK4585","LU2328871848.SGD","BK4578","BK4127","BK0209","BK4588","LU0070302665.USD","NVS","IE00B4R5TH58.HKD","LU1969619763.USD","IE00BJJMRZ35.SGD","BK0183","BK0188","BK0187","BK1191","BK0175","BK4532","IE0002141913.USD","BK4007","000963","LU0320765489.SGD","LU0208291251.USD","BK0132","KCE","IE00B2B36J28.USD","IPOS","IE00BJT1NW94.SGD","BK1574","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}